BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14504477)

  • 1. Characterization of the 5'flanking region of the human Chk1 gene: identification of E2F1 functional sites.
    Carrassa L; Broggini M; Vikhanskaya F; Damia G
    Cell Cycle; 2003; 2(6):604-9. PubMed ID: 14504477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.
    Urist M; Tanaka T; Poyurovsky MV; Prives C
    Genes Dev; 2004 Dec; 18(24):3041-54. PubMed ID: 15601819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human p73 promoter: characterization and identification of functional E2F binding sites.
    Seelan RS; Irwin M; van der Stoop P; Qian C; Kaelin WG; Liu W
    Neoplasia; 2002; 4(3):195-203. PubMed ID: 11988839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
    Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD
    Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.
    Marabese M; Vikhanskaya F; Rainelli C; Sakai T; Broggini M
    Nucleic Acids Res; 2003 Nov; 31(22):6624-32. PubMed ID: 14602923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.
    Yang SZ; Lin FT; Lin WC
    EMBO Rep; 2008 Sep; 9(9):907-15. PubMed ID: 18660752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1.
    Fortin A; MacLaurin JG; Arbour N; Cregan SP; Kushwaha N; Callaghan SM; Park DS; Albert PR; Slack RS
    J Biol Chem; 2004 Jul; 279(27):28706-14. PubMed ID: 15105421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the p53-homologue p73 in E2F1-induced apoptosis.
    Stiewe T; Pützer BM
    Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of the human Cdc2L1 gene promoter.
    Kahle A; Feng Y; A Nelson M
    Gene; 2005 Jan; 344():53-60. PubMed ID: 15656972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.
    Fogal V; Hsieh JK; Royer C; Zhong S; Lu X
    EMBO J; 2005 Aug; 24(15):2768-82. PubMed ID: 16037820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of E2F1 apoptotic target genes in response to DNA damage.
    Pediconi N; Ianari A; Costanzo A; Belloni L; Gallo R; Cimino L; Porcellini A; Screpanti I; Balsano C; Alesse E; Gulino A; Levrero M
    Nat Cell Biol; 2003 Jun; 5(6):552-8. PubMed ID: 12766778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN'-p73 transcript.
    Pützer BM; Tuve S; Tannapfel A; Stiewe T
    Cell Death Differ; 2003 May; 10(5):612-4. PubMed ID: 12728260
    [No Abstract]   [Full Text] [Related]  

  • 16. p73alpha regulation by Chk1 in response to DNA damage.
    Gonzalez S; Prives C; Cordon-Cardo C
    Mol Cell Biol; 2003 Nov; 23(22):8161-71. PubMed ID: 14585975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage.
    Inoue Y; Kitagawa M; Taya Y
    EMBO J; 2007 Apr; 26(8):2083-93. PubMed ID: 17380128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene.
    Koziczak M; Müller H; Helin K; Nagamine Y
    Eur J Biochem; 2001 Sep; 268(18):4969-78. PubMed ID: 11559366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
    Hershko T; Chaussepied M; Oren M; Ginsberg D
    Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.